Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Guisen Yin"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Fulvestrant, as the first selective estrogen receptor degrader, is widely used in the endocrine treatment of breast cancer. However, in the real world, there is a lack of relevant reports on adverse reaction data mining for fulvestrant. To p
Externí odkaz:
https://doaj.org/article/c338f041dc1c4a8aa82ed6bca6b74576
Autor:
Fen Liu1, Guisen Yin2, Shuyi Xue3, Rehman, Faisal UL4, Dehua Liao1, Yong Pan1 panyong@hnca.org.cn
Publikováno v:
Journal of Cancer. 2023, Vol. 14 Issue 17, p3275-3284. 10p.
Publikováno v:
Journal of Cancer. 2024, Vol. 15 Issue 1, p90-102. 13p.
Questions have been raised about the safety of paxlovid and molnupiravir as antiviral drugs for the treatment of COVID-19 since the pandemic. We applied t he FDA Adverse Event Reporting System (FAERS) to assess the safety by performing a disproportio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bc5131851514b3c2eaddaa0bdb4538a7
https://doi.org/10.21203/rs.3.rs-2958788/v1
https://doi.org/10.21203/rs.3.rs-2958788/v1
Publikováno v:
Asian Journal of Organic Chemistry. 5:882-885
A novel and efficient palladium-catalyzed cross-coupling benzylation reaction of pentafluorobenzene through selective C−H functionalization has been developed. A series of carbonates and polyfluorobenzenes have been examined and found to give moder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9893c186c6449d3cca7246a62feb02f4
https://doi.org/10.1002/ajoc.201600204
https://doi.org/10.1002/ajoc.201600204
Publikováno v:
ChemInform. 47
A novel and efficient palladium-catalyzed cross-coupling benzylation reaction of pentafluorobenzene through selective C−H functionalization has been developed. A series of carbonates and polyfluorobenzenes have been examined and found to give moder
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c127142fc6d79268ec9186d12bccc89d
https://doi.org/10.1002/chin.201648073
https://doi.org/10.1002/chin.201648073
Autor:
Yin, Guisen1 (AUTHOR), Song, Guiling2 (AUTHOR), Xue, Shuyi3 (AUTHOR), Liu, Fen4 (AUTHOR) liufen@hnca.org.cn
Publikováno v:
Scientific Reports. 5/18/2024, Vol. 14 Issue 1, p1-9. 9p.
Publikováno v:
Clinical Trials Week; 6/3/2024, p2272-2272, 1p
Publikováno v:
Asian Journal of Organic Chemistry; Jul2016, Vol. 5 Issue 7, p882-885, 4p